"They said I should give up, but I don’t like to give up," the pioneer in delivering mRNA to the body said.
Companies have long sought to partner on research with public universities, which, starved for state funding, eagerly take private dollars.
The drug, Aduhelm, with a listed price tag of $28,200 a year, has had few takers in the medical world.
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.